International Business Machines Corp. (IBM)

144.08
NYSE : Technology Services
Prev Close 144.50
Day Low/High 143.99 / 144.94
52 Wk Low/High 139.13 / 171.13
Avg Volume 4.67M
Exchange NYSE
Shares Outstanding 917.97M
Market Cap 131.95B
EPS 6.20
P/E Ratio 23.57
Div & Yield 6.28 (4.15%)

Latest News

Amazon's New Cloud Deal with Verizon Signals a Bigger Trend

Amazon's New Cloud Deal with Verizon Signals a Bigger Trend

Many large businesses are now opting to shut down existing data centers and move their contents to public clouds. Amazon is well-positioned to grab a large portion of these deals.

Xerox Boots CEO In Deal With Activist Investor Carl Icahn

Xerox Boots CEO In Deal With Activist Investor Carl Icahn

The document technology company also agreed to bring on five dissident directors and replace its CEO. Six existing board members also resigned in a resounding victory for the dissident investors.

Symantec's Problems Run Deeper Than Just an Audit Committee Probe

Symantec's Problems Run Deeper Than Just an Audit Committee Probe

The security firm's weak guidance points to share loss in a very competitive enterprise landscape.

Nvidia's Blowout Quarter

Chip maker posts very strong results for latest quarter.

Akamai's CEO Doesn't Shut Door on a Sale, or Deal of Its Own

Akamai's CEO Doesn't Shut Door on a Sale, or Deal of Its Own

Akamai has had an eventful few months: a good earnings report and a discussion with noted activist investor Elliott Management. The company's CEO Tom Leighton talks with TheStreet about what's next.

IBM Announces Collaboration With North Carolina State University To Accelerate Quantum Computing

NC State to join the IBM Q Network as first university-based IBM Q Hub in North America

Novice Trade: IBM

Novice Trade: IBM

The June 140 puts cost less than $1.85.

Novice Trade: XLK Tech Sector ETF

Novice Trade: XLK Tech Sector ETF

Consider this XLK unhedged long call 'shooter' trade.

Buffett's Optimism Rules: Cramer's 'Mad Money' Recap (Monday 5/7/18)

Buffett's Optimism Rules: Cramer's 'Mad Money' Recap (Monday 5/7/18)

Jim Cramer says Warren Buffett is the greatest investor, and his optimism has suffused trading and has been justified.

Jim's Daily Rundown

Jim discusses CNBC's interview with Warren Buffett, Saturday's sitdown at TheStreet's Investors Bootcamp with PayPal CEO Dan Schulman and more!

3 Tech Stock Ideas Besides Apple for Warren Buffett Fans

3 Tech Stock Ideas Besides Apple for Warren Buffett Fans

Though it's hard to find tech stocks that meet Berkshire Hathaway's standards for predictable cash flows and strong moats, these firms arguably fit the bill.

Jim Cramer: Uncle Warren's Big Weekend

Jim Cramer: Uncle Warren's Big Weekend

Most important, for us, there will be talk of stocks galore, especially Buffett's portfolio.

If Warren Buffett Wants to Hold Apple's Stock Forever, You Should Too

If Warren Buffett Wants to Hold Apple's Stock Forever, You Should Too

Billionaire investor Warren Buffett reportedly has bought a ton more Apple stock. The purchase is the clearest sign yet that the tech giant remains one of the best bets in the market.

Unreasonable Expectations: Cramer's 'Mad Money' Recap (Tuesday 5/1/18)

Unreasonable Expectations: Cramer's 'Mad Money' Recap (Tuesday 5/1/18)

Expectations about earnings are totally out of whack, says Jim Cramer. Will Apple's earnings break the spell?

Jim Cramer: Markets Expect Too Much from Under Armour, IBM and These Other Names

Jim Cramer: Markets Expect Too Much from Under Armour, IBM and These Other Names

The stocks inexplicably fell even after they delivered good earnings.

See How International Business Machines Ranks Among Analysts' Top Dow 30 Picks

A study of analyst recommendations at the major brokerages shows that International Business Machines Corp is the #25 broker pick, on average, out of the 30 stocks making up the Dow Jones Industrial Average, according to ETF Channel. Within the broader S&P 500, when components were ranked in terms of analyst favorites, IBM claims the #366 spot.

It's Dumb Not to Have Investments in Cryptocurrencies, Cannabis in a Portfolio

It's Dumb Not to Have Investments in Cryptocurrencies, Cannabis in a Portfolio

Traditional, blue-chip stocks and FANG just aren't cutting it right now. Smart investors will consider alternative strategies to diversify out of the same-old, same-old.

Intel's Latest Manufacturing Delay Is Taking the Shine Off Its Strong Earnings

Intel's Latest Manufacturing Delay Is Taking the Shine Off Its Strong Earnings

Though the chip giant beat estimates and issued strong guidance, it also disclosed a new manufacturing process delay that could give rivals an opening.

Jim Cramer: This Time It's the Data Center, Not PCs

Jim Cramer: This Time It's the Data Center, Not PCs

That's the true takeaway of last night's conference calls from the big dogs, Microsoft, Intel and Amazon.

3 Hot Reads From TheStreet's Top Premium Columnists

3 Hot Reads From TheStreet's Top Premium Columnists

Jim Cramer and our other experts discuss Verizon, Procter & Gamble, IBM, Amazon and Alphabet.

Jim Cramer: If You're Afraid of the 10-Year Yield, Go to Cash

Jim Cramer: If You're Afraid of the 10-Year Yield, Go to Cash

If you're so worried about the rising 10-Year Treasury yield, which touched 3% on Tuesday, stick to cash, according to TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer.

The Clouds Are Parting for Amazon

The Clouds Are Parting for Amazon

The company's biggest opportunity isn't in retail.

Jim Cramer: IBM, P&G Deserve a Look-See

Jim Cramer: IBM, P&G Deserve a Look-See

These stocks are very compelling while Verizon is what I would call an intended high yielder.

3 Big-Cap Tech Options Trades to Make Now

3 Big-Cap Tech Options Trades to Make Now

Here are a few of my better ideas heading into earnings reports.

IBM Watson Health Finds Nation's Top-Performing Health Systems Deliver More Consistent Care Across Member Hospitals

Watson Health 15 Top Health Systems Study, Formerly Truven Health Analytics 15 Top Health Systems, Measures Hospital Alignment, Identifies Healthcare Organizations Delivering Better Outcomes at Lower Cost

TheStreet Quant Rating: B (Buy)